First comparison of common breast cancer tests finds varied accuracy of predictions
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence...
List view / Grid view
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence...
Study shows first applications of DNA origami for nanomedicine...
Injecting minute amounts of two immune-stimulating agents directly into solid tumours in mice can eliminate all traces of cancer...
Scientists in the United States have discovered that two existing FDA-approved drugs, clofarabine (Clolar™) and cladribine (Leustatin™), have a powerful inhibitory impact on Ewing sarcoma cells in the lab.
The FDA has approved Lutathera for the treatment of a type of cancer that affects the pancreas the gastrointestinal tract...
Addition of hydroxyurea to current chemotherapy significantly improved survival in animal models of glioblastoma...
Cardiff Metropolitan University has been instrumental in the development of a new anti-cancer agent that has the potential to offer a valuable treatment option for cancer...
The FDA has approved Ogivri as a biosimilar to Herceptin for the treatment of patients with breast or metastatic stomach cancer whose tumours overexpress the HER2 gene...
Researchers at NYU Langone Health's Perlmutter Cancer Center report that at least three kinds of bacteria in the mouths of Americans may directly affect their risk of developing oesophageal cancer.
An immunotherapy drug can be used to cure a rare type of cancer arising from pregnancy when existing treatments have failed...
Cell-weighing technique may predict which therapies a patient is most sensitive or resistant to...
A study has shown that Adipocytes can absorb and metabolise the chemotherapeutic agent daunorubicin, reducing its ability to kill cancer cells.
Proton beam therapy, in combination with chemotherapy, may be a better treatment option than traditional radiation therapy techniques...
The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot....
Scientists have used genome sequencing to gain a better understanding of the biology underlying chordoma...